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The role of maxillary sinus puncture on the diagnosis and 
treatment of patients with hospital-acquired rhinosinusitis
Abstract
José Arruda Mendes Neto1, Viviane Maria Guerreiro2, Elcio Roldan Hirai3, Eduardo Macoto Kosugi4, 
Rodrigo de Paula Santos5, Luis Carlos Gregório6
Rhinosinusitis is one of the most commom causes of fever of unknown origin in critically ill 
patients and should be systematically searched.
Objective: This study aims to evaluate the diagnostic and therapeutic effect of maxillary sinus puncture 
performed at the bedside in patients with infective rhinosinusitis hospitalized in an Intensive Care 
Unit of a high complexity care hospital.
Materials and Methods: This retrospective study looks into patients on mechanical ventilation with 
fever of unknown origin and signs of rhinosinusitis on CT images who were submitted to inferior 
meatus maxillary sinus puncture.
Results: The total study sample consisted of 27 patients (70.3% male; mean age 45.3 years). The 
most common Intensive Care Unit admission diagnoses were head trauma and stroke. CT scans 
revealed the maxillary (85.2%) and sphenoid (74.1%) sinuses were the most involved paranasal 
sinuses. Middle meatus purulent drainage was seen in 30.7% of the nasal cavities. Fever was reduced 
in 70.4% of the patients after puncture (p < 0.001). The most commonly found organisms in sinus 
aspirates were Pseudomonas aeruginosa and Acinetobacter baumannii.
Conclusion: Maxillary sinus puncture performed at the bedside of the patients is an important 
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INTRODUCTION
Hospital infection (HI) is defined as an infection 
related to hospitalization or medical procedures carried 
out in a hospital setting acquired by the patient after ad-
mission that manifests during hospitalization or up to 72 
hours after discharge1.
Studies indicate that the most common type of ICU 
HI is ventilator-associated pneumonia (VAP). Other fre-
quent causes of HI are urinary tract infections associated to 
the use of indwelling bladder catheter and catheter-related 
bloodstream infections. These three causes account for 
over 80% of ICU HI cases2-4.
Infective rhinosinusitis (IRS) is usually not men-
tioned in large international and national studies on HI, 
and remains as a topic discussed only in epidemiology 
studies on infections on severe patients2,3,5. Nonetheless, 
several papers have described IRS as one of the main 
causes of fever in ICUs2,6-8.
The diagnosis of IRS in ICU patients can be chal-
lenging for otorhinolaryngologists. In this group of sedated 
immune-depressed patients, the classic signs of rhinosinus-
itis are mostly absent9,10. Clinical findings are nonspecific, 
and patients have fever and are often diagnosed with 
leukocytosis3,8,11,12. Once other possible foci of infection are 
ruled out, ENTs are called to assess these critical patients 
with fever of unknown origin (FUO), leukocytosis, and 
signs of disorder on imaging tests.
Paranasal sinus CT scans and nasal endos-
copy are the most important noninvasive tests 
used to assess ICU patients. Presence of air-fluid level, 
complete sinus opacification or mucosal thickening 
greater than 6 mm combined with purulent secretion in 
the middle meatus visualized during endoscopic exami-
nation are deemed as important signs in the diagnosis of 
sinusitis13.
Patients with FUO and radiologic signs of rhinosi-
nusitis are first advised to remove all nasal devices6,14-16. Ad-
ditionally, topical nasal vasoconstrictors are administered 
for at least 72 hours before they are offered an invasive 
procedure17.
If the patient fails to respond to these ini-
tial measures, it is recommended that the infect-
ed secretion be drained from the paranasal si-
nus8,12,14,15. This procedure offers the possibility of con-
firming the diagnosis of IRS and improving the patient’s 
overall condition.
Maxillary sinus puncture is considered the gold 
standard to diagnose IRS in ICU patients8,12,14,15. Besides 
offering clinical samples used to identify the causing agent 
of infective syndromes, it may also serve as an important 
tool in the treatment of this group of patients6,12,15. Authors 
have described success rates of approximately 70% in 
managing fever after removing infected secretion from the 
maxillary sinus14. The great advantage of this procedure 
is that it can be performed at the bedside in the ICU, thus 
reducing the risk of adverse effects connected to taking 
the patients to the OR18.
Critical rhinosinusitis patients with fever refractory 
to the procedure are traditionally referred to functional 
endoscopic sinus surgery. They are given general anes-
thesia to allow for the removal of all infected secretion, 
excision of local inflammatory tissue, and ventilation of 
the involved paranasal sinuses16,17,19.
However, ICU patients are at a higher risk for sur-
gery, as they are immunocompromised and unstable from 
the hemodynamic and metabolic standpoints. Addition-
ally, these individuals often present relevant coagulation 
disorders. Therefore, surgery should only be offered as a 
last resort for these patients.
This study aims to assess the role of maxillary sinus 
puncture at the bedside in the diagnosis and treatment of 
patients with infective rhinosinusitis admitted to the ICU 
of a high complexity university hospital.
MATERIALS AND METHODS
This retrospective study looks into the ENT assess-
ment of ICU patients with radiologic signs of rhinosinusitis 
with fever of unknown origin (axillary temperatures equal 
to or greater than 37.8°C) on ventilation staying at a high 
complexity hospital.
FOU was defined as fever not linked to identi-
fied disease or cases in which patients failed to respond 
despite being given proper therapy for a previously di-
agnosed condition, according to the protocol in effect at 
this service.
The patients and procedures described in this study 
were cared for and performed by a team of physicians 
made up by two ENT resident medical doctors (second and 
third year residents) and one ENT specialized in rhinology 
who led the team.
This study and the informed consent form presented 
to the patients were approved by the Ethics Committee of 
our institution and granted permit # 1158/09.
The patients enrolled in this study had to meet 
specific inclusion and exclusion criteria (consecutive al-
location).
The inclusion criteria were:
•	 time of hospitalization greater than 48 hours;
•	 use of invasive ventilation;
•	 presence of fever of unknown origin (axillary 
temperature ≥ 37.8°C);
•	 maxillary sinus involvement verified in CT 
scans;
•	 fever persisting despite the administration of 
xylometazoline twice a day for 72 hours;
•	 absence of nasal devices for at least 72 hours;
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•	 paranasal sinus puncture positive for infec-
tion (presence of purulent secretion and/or 
evidences of bacterial growth).
The exclusion criteria were:
•	 facial trauma with direct involvement of the 
paranasal sinuses;
•	 deviated septum touching the nasal lateral 
wall, increasing the complexity of the punctu-
re procedure when done through the inferior 
meatus;
•	 polyps, antrochoanal polyps, and other nasal 
lesions.
Three tools were used to assess patient findings:
A- Nose endoscopy: the patients were examined 
with a 3.1 mm flexible fiberscope; presence of purulent 
secretion in the middle meatus was deemed as a sign 
suggestive of IRS.
B- Paranasal sinus CT scans: presence of complete 
opacification, air-fluid level, or mucosal thickening ≥ 6 mm.
C- Paranasal sinus puncture: positive diagnosis 
was defined when purulent secretion and/or evidence of 
bacterial growth were found20,21.
Patients underwent maxillary sinus puncture via 
the inferior meatus to treat IRS7,12 (Figure 1). IRS cases 
refractory to puncture were treated through functional 
endoscopic sinus surgery (FESS); patients were placed 
under general anesthesia to have their involved sinuses 
meticulously drained16,17,22,23. Proper antibiotics were admi-
nistered by the intensive care team and infectologists, as 
verified by the analysis done on secretion aspirate cultures.
Fever abatement was used as a parameter to assess 
intervention effectiveness. The patients who failed to evol-
ve favorably even after surgery were reassessed clinically 
and radiologically through control paranasal sinus CT 
scans. After discussing the case with the patient and the 
ICU team, a new procedure was offered whenever it was 
deemed necessary.
Sinus aspirates and sinus washout contents were 
collected and sent in sterile containers for culturing and 
antibiogram analysis.
The variables considered for analysis were patient 
gender, age, diagnosis on ICU admission, involved paranasal 
sinus (radiological signs), alterations on physical examination 
(presence or absence of purulent secretion in the middle 
meatus), clinical improvement after puncture, culture results, 
occurrence of adverse events related to the procedures, need 
for surgery, improved clinical outcome with surgery.
This paper used a statistical significance level of 
0.05 (5%). Statistical analysis was done using the test for 
equality of two proportions. The test for equality of two 
proportions is a non-parametric test (used in low sampling) 
compares the proportion of answers of two variables and 
whether their levels are statistically significant.
Software products SPSS V16, Minitab 15 and Excel 
Office 2007 were used in statistical analysis.
RESULTS
This study enrolled 27 critical patients assessed by 
the rhinology service physicians of a university hospital 
between March of 2007 and September of 2010.
Patient data can be seen on Table 1. The study 
flowchart is presented in Figure 2.
Figure 1. Left inferior meatus. 1: Inferior nasal concha; 2: Hasner’s 
valve; 3: Site of puncture on the lateral wall of the left inferior meatus.
Onset of defervescence (reduction on the number of 
daily peaks of fever) within 48 to 72 hours16,17 or abolition 
of fever within five days of the procedure17 where used to 
characterize the success of the puncture procedure. The 
same criteria was used to assess the success of FESS16,17,22,23.
Table 1. Characteristics of the patients enrolled in the study 
(n = 27).
Characteristics




Most frequent diagnosis at admission
- Head trauma 11 (40.74%)
- Stroke 4 (14.8%)
- Other neurological syndromes 3 (11.1%)
n = number of subjects.
* Mean values ± standard deviation (SD).
Fifty-four nasal cavities were analyzed through CT 
scans. All patients had radiological signs of unilateral or 
bilateral maxillary and sphenoidal rhinosinusitis (Figure 3). 
Two patients (7.4%) had all paranasal sinuses involved as 
seen in CT scans.
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Figure 2. Study organizational flowchart. n = number of subjects.
Figure 3. Distribution of paranasal sinuses with radiological sings of 
rhinosinusitis. n = number of nasal cavities.
Twenty-six nasal cavities (13 patients) were 
examined through endoscopy for the presence of al-
terations suggestive of rhinosinusitis in the middle meatus 
(Table 2).
Glycopeptide antibiotics were the most used antimi-
crobial agents in this study (Figure 4). The most common 
drug combinations were glycopeptides and carbapenems 
(42.6%), and glycopeptides and fourth generation cepha-
losporins (38.1%).
Table 2. Distribution of nasal endoscopic examination with 
findings of purulent secretion in the middle meatus.
Purulent secretion
Nasal endoscopy (n = 26)
N %
Middle meatus 8 30.7
n = number of subjects.
N = Number of nasal cavities with purulent secretion.
Figure 4. Distribution of antibiotics administered to patients diagnosed 
with infective rhinosinusitis.
Forty-six maxillary sinus puncture procedures were 
performed, based on the alterations found on paranasal CT 
scans. Postoperative clinical improvement was observed 
in 70.4% of the patients (Table 3).
No complications were recorded in the maxillary 
sinus puncture procedures.
Microbiological analysis was done for 26 patients, 
and at least one agent responsible for IRS was found 
(Figure 5).
Eight patients (29.6%) underwent FESS. After sur-
gery, seven patients (87.5%) improved from fever and one 
(12.5%) did not (Table 4). The cause of fever in this patient 
was attributed to the relapse of a previously diagnosed 
digestive system tumor.
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n % n %
8 29.6% 19 70.4% < 0.001
n = number of subjects.
* Test for equality of two proportions.
Figure 5. Distribution of microbiological analyses of maxillary sinus 
aspirates.





n % n %
1 12.5 7 87.5 < 0.001
n = number of subjects.
* Test for equality of two proportions.
DISCUSSION
IRS is one of the causes for fever of unknown 
origin in ICU patients and, as such, must be thoroughly 
investigated2,3,6,7. This infective syndrome increases patient 
morbidity and may be associated with difficulty managing 
some diseases such as VAP.
Prevalence rates were higher among male patients 
in this study. Head trauma was the main cause for hospi-
talization in the studied population. These findings were 
similar to those seen in the literature9,13,16,24. This population 
comprises a group of severe patients who often require 
prolonged hospitalization. Additionally, they are often on 
ventilation for longer periods of time (hyperventilation) to 
control intracranial pressure levels16. Consequently, some 
authors have described lower levels of consciousness, 
scores under 7 in the Glasgow coma scale, and/or head 
trauma as risk factor for IRS25.
The same imaging criteria described in the literature 
were used in this study: air-fluid level, complete opaci-
fication, or mucosal thickening greater than 6 mm24,26,27. 
In general terms, the most frequently involved paranasal 
sinuses were the maxillary and the sphenoidal, as seen 
in 85.2% and 74.1% of the nasal cavities respectively. The 
ethmoid and frontal sinuses also presented significant 
rates of involvement. Some authors have described a 
positive correlation between sinus disease and length of 
intubation20,28, i.e., the longer the period the patient is on 
the ventilator the greater the number of involved parana-
sal sinuses. All patients in this study were intubated for 
over two weeks, which possibly led to the high rates of 
involvement observed.
One of the most characteristic diagnostic signs of 
rhinosinusitis is purulent secretion in the middle meatus. 
Only 30.7% of the nasal cavities of the critical patients 
enrolled in this study were blocked. Kountakis et al.13 e 
Skoulas et al.24 described rates of 25.2% and 40.3% res-
pectively. These low rates indicate that the classic endos-
copic signs of rhinosinusitis may be absent in most ICU 
patients, given the altered levels of immune response of 
this population9,10.
ICU patients with hospital infection were being 
treated empirically with broad specter antibiotics at 
the time of their ENT examination. Initial therapy for 
FUO individuals must consider the endemic hospital 
bacterial flora. Glycopeptides, carbapenems, and four-
th generation cephalosporins were the most frequently 
used drugs. The drugs were changed by the ICU medi-
cal staff and infectologists based on the results of sinus 
aspirate cultures. There is no consensus in the literature 
as to the duration of antibacterial administration, but a 
minimum of seven days of drug therapy seems to be 
necessary7,15.
Some authors believe that antibacterial therapy alo-
ne is not enough to treat IRS patients. Studies have shown 
that ICU patients with IRS still had fever even when the 
concentration of antibiotic drugs in their sinus aspirates 
was high enough to attain the minimum inhibitory level 
to eliminate bacteria. A complex set of pathologic varia-
bles can be used to explain this event, among which is 
the formation of a biofilm in the nasal mucosa preventing 
antibacterial drugs from reaching their targets. These au-
thors concluded that drainage of the infected secretion is 
required to treat IRS20.
Patients with FUO and radiological signs of rhino-
sinusitis are advised to remove their nasal devices as part 
of their initial assessment. Various papers have described 
nasal devices as one of the main risk factors for the deve-
lopment of IRS8,14-16. These devices may press against the 
ostiomeatal complex and mechanically block the sinus 
ostium. Additionally, trauma produced by this tube may 
trigger an inflammatory response in the nasal mucosa, 
mucosal edema, increased secretion, and alterations in 
the property of mucous fluid29.
Other factors have been associated with increased 
nasal congestion in these individuals: prolonged periods 
in dorsal decubitus, high central venous pressure, and 
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positive pressure ventilation. These factors increase jugular 
venous pressure, thus congesting the vessels in the nasal 
mucosa29.
Therefore, patients are required to remove their 
nasal devices and use nasal topical vasoconstrictors for 
72 hours before undergoing invasive procedures8,17,25. 
These measures may reverse the inflammatory process 
in some individuals and facilitate the drainage of sinus 
secretions.
Many studies have indicated maxillary sinus 
puncture as the standard procedure used in to diagnose 
IRS8,12,22,26,30. This procedure may also be a relevant tool 
in the treatment of critical patients with IRS8,12,22,26,30. This 
study revealed that 70.4% of the patients improved from 
their fever episodes after the procedure. This outcome is 
similar to that published by Salord et al.14 and Rouby et 
al.26. In the study by Caplan & Hoyt25, 58.8% of the patients 
improved from fever, while Ramadan et al.15 published 
improvement rates of 83%.
No complications were recorded in the maxillary 
sinus puncture procedure.
Community-acquired rhinosinusitis is usually caused 
by Streptococcus pneumoniae and Haemophilus influen-
zae. Hospital rhinosinusitis has been related to colonization 
by endogenous bacteria and pathogens exogenous to the 
ICU environment29. The most frequently microorganisms 
observed in our study were Pseudomonas aeruginosa 
(30.7%), Acinetobacter baumannii (23.1%), Proteus mi-
rabilis (15.4%) and coagulase-negative Staphylococcus 
(15.3%). The results of microbiologic analysis indicate that 
the changes in the nasal and systemic immune profile of 
these critical patients may enable pathogens to colonize 
the patients’ airways and trigger the onset of IRS. Similar 
findings were previously reported in the literature8,21,27,30-32.
Poorly cared for pharynxes, oral cavities and teeth 
may play an important role in the colonization of paranasal 
sinuses by bacterial pathogens29. Gastric protection and 
nasoenteral tubes often used in severe patients also favor 
the spread of bacteria in the stomach29.
Previously used nasal devices and the injured muco-
sa around them may offer a good bed for the development 
of pathogens. Bacteria populations may grow in these 
areas and form biofilms. P. aeruginosas and S. aureus 
have mucus and respiratory epithelial cell receptors. As A. 
baumannii, they also produce glycocalyx, which adheres 
to polyvinyl chloride, a material present in endotracheal 
tubes7. In this study, P. aeruginosas and A. baumannii 
were the most frequently observed pathogens. Therefore, 
the presence of biofilm in the nasal mucosa may trigger 
ongoing inflammatory response and sustained fever epi-
sodes even after the infected secretion has been removed 
from the patients’ sinuses. The high rates of involvement 
of posterior paranasal sinuses, more specifically of the 
sphenoidal sinus19,20, may be a factor in the therapeutical 
failure of the maxillary sinus puncture procedure15. These 
factors may account for the clinical failure of the puncture 
procedure in these patients.
In this study, FESS was indicated for patients who-
se puncture procedures failed to resolve their IRS. In all, 
87.5% of the patients improved from fever after FESS. 
Pádua et al.19 also described a high success rate (82%) 
with surgery.
CONCLUSION
Maxillary sinus puncture at the bedside enabled 
the identification of at least one significant pathogen 
responsible for hospital infective rhinosinusitis. The most 
frequently observed pathogens were Pseudomonas ae-
ruginosa (30.4%) and Acinetobacter baumannii (23.1%). 
The procedure proved to be a relevant therapeutical tool, 
and showed success rates of 70.4% in managing patient 
fever.
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